ArticleNPJ vaccines2026

An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication.

Roberta L Pagni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.